Episodes Part I of Understanding Multiple Myeloma Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA A Conversation on AML: Diagnosis and Treatment Alice Mims, MD, MSCR, The James, The Ohio State University Comprehensive Cancer Center, Columbus, OH BPDCN – Expert Insight Into a Rare Blood Cancer Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX Post navigation « Previous 1 2 3 4 CategoriesCategories Select Category All Episodes (93) CAR T-cell Therapy (10) Clinical Trials (4) COVID-19 (7) General Treatment & Support (31) Genomics (3) Health Equity (8) Leukemia (22) Lymphoma (14) Minimal Residual Disease (MRD) (4) Myelodysplastic Syndromes (5) Myeloma & Amyloidosis (12) Myeloproliferative Neoplasms (3) Pediatric and AYA (12) Rare Blood Cancers (4) Transplantation (4) Waldenström macroglobulinemia (2)
Part I of Understanding Multiple Myeloma Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA
A Conversation on AML: Diagnosis and Treatment Alice Mims, MD, MSCR, The James, The Ohio State University Comprehensive Cancer Center, Columbus, OH
BPDCN – Expert Insight Into a Rare Blood Cancer Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX